documents: FDA-2023-N-2177-6954

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-2177-6954 FDA FDA-2023-N-2177 Reference 104 - Zhang, et al., “An Overview of Characteristics of Clinical Next-Generation Sequencing–Based Testing for Hematologic Malignancies” Supporting & Related Material Background Material 2024-05-06T04:00:00Z 2024 5     2024-05-06T16:18:40Z   0 0 0900006486529a18

Links from other tables